TTD | Drug: D04YHG

Drug General Information
Drug ID	D04YHG
Former ID	DIB012378
Drug Name	ErepoXen
Indication	Anemia [ICD9: 280-285; ICD10:D50-D64]		Phase 3	[549217]
Company	Lipoxen plc
Target and Pathway
Target(s)	Erythropoietin Receptor	Target Info	Agonist	[528354]
KEGG Pathway	Cytokine-cytokine receptor interaction
	PI3K-Akt signaling pathway
	Jak-STAT signaling pathway
	Hematopoietic cell lineage
NetPath Pathway	TGF_beta_Receptor Signaling Pathway
Pathway Interaction Database	Signaling events mediated by Stem cell factor receptor (c-Kit)
Pathway Interaction Database	EPO signaling pathway
WikiPathways	EPO Receptor Signaling
References
Ref 549217	Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800033828)
Ref 528354	Combination erythropoietin-hydroxyurea therapy in sickle cell disease: experience from the National Institutes of Health and a literature review. Haematologica. 2006 Aug;91(8):1076-83.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.

Drug Information